Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 6/20 | 0.70 |
| ▸ | CA2 | P00918 | 6/20 | 0.70 |
| ▸ | CA12 | O43570 | 5/20 | 0.70 |
| ▸ | CA9 | Q16790 | 5/20 | 0.70 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.70 |
| ▸ | CA7 | P43166 | 2/20 | 0.70 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.70 |
| ▸ | TSHR | P16473 | 1/20 | 0.65 |
| ▸ | MAPT | P10636 | 3/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.61 |
| ▸ | EGFR | P00533 | 1/20 | 0.59 |
| ▸ | ERN1 | O75460 | 1/20 | 0.59 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | SETD7 | Q8WTS6 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | XDH | P47989 | 1/20 | 0.56 |
| ▸ | CASP3 | P42574 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Biphenyl Dimethyl Dicarboxylate SCHEMBL68521 | 1.00 | CA1 (0.70) | CA1CA2CA12CA9CA14 | |
| Biphenyl Dimethyl Dicarboxylate SCHEMBL2890577 | 0.97 | CA1 (0.67) | CA1CA2CA12CA9CA14 | |
| SCHEMBL16749645 | 0.93 | CA1 (0.61) | CA1CA2CA12CA9CA14 | |
| SCHEMBL10009170 | 0.93 | CA1 (0.61) | CA1CA2CA12CA9CA14 | |
| SCHEMBL27589486 | 0.93 | TSHR (0.64) | CA1CA2CA12CA9CA14 | |
| SCHEMBL28993944 | 0.92 | CA1 (0.80) | CA1CA2CA12CA9CA14 | |
| SCHEMBL23600 | 0.92 | CA1 (0.80) | CA1CA2CA12CA9CA14 | |
| SCHEMBL4668655 | 0.91 | CA1 (0.87) | CA1CA2CA12CA9CA14 | |
| SCHEMBL13019491 | 0.91 | TDP1 (0.87) | CA1CA2CA12CA9CA14 | |
| SCHEMBL8365053 | 0.91 | CA1 (0.87) | CA1CA2CA12CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230250338-A1 | COMPOUND AND LIQUID CRYSTAL COMPOSITION | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2023-08-10 | — | — | US | disclosed |
| US-20230250338-A1 | COMPOUND AND LIQUID CRYSTAL COMPOSITION | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2023-08-10 | — | — | US | disclosed |
| US-10953393-B2 | Stabilization of active metal catalysts at metal-organic framework nodes for highly efficient organic transformations | THE UNIVERSITY OF CHICAGO (US) | 2021-03-23 | — | — | US | disclosed |
| US-10953393-B2 | Stabilization of active metal catalysts at metal-organic framework nodes for highly efficient organic transformations | THE UNIVERSITY OF CHICAGO (US) | 2021-03-23 | — | — | US | disclosed |
| US-10301331-B2 | Separation of metal-organic frameworks | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2019-05-28 | — | — | US | disclosed |
| US-20180361370-A1 | STABILIZATION OF ACTIVE METAL CATALYSTS AT METAL-ORGANIC FRAMEWORK NODES FOR HIGHLY EFFICIENT ORGANIC TRANSFORMATIONS | NATIONAL SCIENCE FOUNDATION | 2018-12-20 | — | — | US | disclosed |
| US-20180201629-A1 | SEPARATION OF METAL-ORGANIC FRAMEWORKS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2018-07-19 | — | — | US | disclosed |
| US-20180201629-A1 | SEPARATION OF METAL-ORGANIC FRAMEWORKS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2018-07-19 | — | — | US | disclosed |
| US-9771517-B2 | Liquid-crystal optical modulation element | DIC CORPORATION (JP) | 2017-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10953393-B2 | Stabilization of active metal catalysts at metal-organic framework nodes for highly efficient organic transformations | SBK1, SIK1, SIK2 | CA1 442/4885CA2 79/4885CA12 357/4885 |
| US-20180361370-A1 | STABILIZATION OF ACTIVE METAL CATALYSTS AT METAL-ORGANIC FRAMEWORK NODES FOR HIGHLY EFFICIENT ORGANIC TRANSFORMATIONS | SBK1, SIK1, SIK2 | CA1 442/4885CA2 79/4885CA12 357/4885 |
| US-20180201629-A1 | SEPARATION OF METAL-ORGANIC FRAMEWORKS | HNRNPF, HNRNPU, PUF60 | CA1 577/4885CA2 1582/4885CA12 385/4885 |
| US-10301331-B2 | Separation of metal-organic frameworks | HNRNPF, HNRNPU, PUF60 | CA1 577/4885CA2 1582/4885CA12 385/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.